Johne's disease is a chronic granulomatous enteritis of cattle caused by the facultative intracellular pathogen Mycobacterium avium subsp. paratuberculosis. Cattle are infected as young calves by ingesting M. avium subsp. paratuberculosis-contaminated milk or feces. Cattle become clinically ill after a 3-to 5-year incubation period. Clinical symptoms include chronic diarrhea, emaciation, and dehydration (9). Johne's disease occurs worldwide (9) and causes estimated annual financial losses of $1.5 billion in the United States (24) . Recent research has also implicated M. avium subsp. paratuberculosis as a possible cause of Crohn's disease in humans (10, 31, 34, 43) . Despite the importance of this disease, the mechanism of protective immunity to M. avium subsp. paratuberculosis infection is not clear.
Mononuclear phagocytes are thought to be the principal effector cells in cell-mediated immunity against mycobacterial infections (35) . Mononuclear phagocytes can be activated by certain cytokines to kill or inhibit intracellular pathogens by oxygen-independent and oxygen-dependent mechanisms (6, 29, 37, 39) . Gamma interferon (IFN-␥) is perhaps the most important and intensively studied cytokine that can activate antimycobacterial mechanisms of murine mononuclear phagocytes (6, 35) . The essential role of IFN-␥ in the resistance of mice to mycobacterial infections was clearly demonstrated by reports that IFN-␥ and IFN-␥ receptor gene knockout mice cannot control M. tuberculosis infection in vivo (11, 13, 20, 25) . IFN-␥ alone has been reported to activate murine macrophages to kill or inhibit M. tuberculosis, M. bovis, M. avium, and M. leprae in vitro (1, 4, 18, 22) .
IFN-␥ alone, or IFN-␥ together with lipopolysaccharide (LPS) or tumor necrosis factor alpha (TNF-␣), can activate murine macrophages to kill or inhibit mycobacteria by the induction of nitric oxide (8, 14, 19, 22) , which is produced by oxidation of L-arginine by inducible nitric oxide synthase (iNOS) (42) . iNOS is maximally induced in murine mononuclear phagocytes stimulated with IFN-␥ and LPS or with IFN-␥ and TNF-␣ (32, 42) . The induction of nitric oxide has been directly related to the capacity of IFN-␥-activated murine macrophages to inhibit or kill M. tuberculosis, M. avium, and M. leprae in vitro (1, 8, 14, 19) . Moreover, inhibition of nitric oxide production in vivo increased mortality, bacillary burden, and tissue damage in mice infected with virulent M. tuberculosis (7) . Furthermore, IFN-␥ and IFN-␥ receptor gene knockout mice that fail to produce nitric oxide were unable to restrict the growth of M. tuberculosis or M. bovis in vivo (13, 20, 26) .
The roles of IFN-␥ and nitric oxide in protective immunity to mycobacterial infections in other mammalian species are less clear. In humans, contradictory effects of IFN-␥ have been observed in vivo and in vitro. IFN-␥ treatment of patients with refractory disseminated nontuberculous mycobacterial infection resulted in marked clinical improvement (23) . Local administration of IFN-␥ to lepromatous leprosy lesions remarkably reduced the bacillary burden (27) . In contrast, IFN-␥ alone has been shown to have no effect on (40, 44) or even to enhance (16) the intracellular growth of mycobacteria in human macrophages in vitro. There is considerable controversy with regard to whether human mononuclear phagocytes can produce nitric oxide and the role that nitric oxide plays in the human immune response to microbial infections (3, 15) .
Comparable studies of the roles of IFN-␥ and nitric oxide in the bovine immune response to mycobacterial infections have not been performed. A recent report showed that IFN-␥ was produced in vitro by M. bovis purified protein derivative (PPD)-stimulated peripheral blood leukocytes (PBLs) from cattle experimentally infected with M. bovis (17) . We also observed that IFN-␥ was produced in vitro by M. avium PPDstimulated PBLs from cows experimentally infected with M. avium subsp. paratuberculosis (46) . These data suggest that IFN-␥ may play a role in the bovine immune response to mycobacterial infections in vivo. We and others also found that bovine monocytes and macrophages can be induced to produce nitric oxide when stimulated with recombinant (r) IFN-␥ and LPS in vitro (45, 47) . Other investigators have cloned the bovine iNOS gene (2) . However, the effects of rIFN-␥ induction of nitric oxide on the intracellular multiplication of mycobacteria in bovine mononuclear phagocytes have not been reported. In the present study, we examined the effects of IFN-␥ and nitric oxide on the interaction of M. avium subsp. paratuberculosis with bovine monocytes.
MATERIALS AND METHODS
Animals. Healthy 1-to 4-year-old Holstein cows were used as blood donors. These animals were free of paratuberculosis as determined by repeated fecal culture and the use of a commercial diagnostic kit (IDEXX Laboratories, Westbrook, Maine) for measurement of serum antibodies to M. avium subsp. paratuberculosis (46) .
Culturing of bovine monocytes. Blood was collected from the jugular vein by venipuncture, with sodium citrate (0.38% [vol/vol] final concentration) being used as an anticoagulant. The blood was centrifuged for 20 min at 400 ϫ g, and the plasma was removed. Blood cells were centrifuged at 600 ϫ g for 20 min, and the buffy coat was carefully removed. The buffy coat cells were resuspended in 30 ml of Hanks' balanced salt solution (HBSS; Gibco, Grand Island, N.Y.), layered over 15 ml of Ficoll-Hypaque (density, 1.077; Accurate Chemical & Scientific Corporation, Westburg, N.Y.), and centrifuged at room temperature for 30 min at 600 ϫ g. The mononuclear cells were collected from the interface and washed three times in HBSS. The isolated mononuclear cells, whose viability was 95% as determined by trypan blue exclusion, were adjusted to a concentration of 3 ϫ 10 6 /ml in HBSS with 0.5% fetal bovine serum (FBS; Gibco). The cells were distributed into the wells (1.0 ml per well) of a 24-well tissue culture plate (Costar, Cambridge, Mass.). In some wells, 10-mm-diameter sterile glass cover slips were added for subsequent acid-fast staining of the infected monolayers. To allow the monocytes to adhere, the plates were incubated at 39ЊC in 5% CO 2 for 2 h, at which time the wells were washed three times with warm HBSS to remove the nonadherent cells. Adherent monocytes were cultured in RPMI 1640 tissue culture medium with 4 mM glutamine (Gibco), 10% FBS (Gibco), 100 U of penicillin G per ml, and 15 g of polymyxin B sulfate per ml at 39ЊC in 5% CO 2 . The number of adherent monocytes was approximately 2 ϫ 10 5 to 5 ϫ 10 5 /well, as determined by the method of Nakagawara and Nathan (36) involving lysing the monolayers with a solution containing 0.1 M citric acid, 0.05% naphthol blue black, and 1.0% Triton X-100 (Sigma, St. Louis, Mo.) and microscopically enumerating the nuclei (magnification, ϫ100).
Bacteria. M. avium subsp. paratuberculosis BO45 was isolated from a cow with clinical Johne's disease that was treated at the University of Wisconsin-Madison Veterinary Medical Teaching Hospital (30) . The bacteria were grown in tissue culture flasks to a final concentration of 10 8 CFU/ml in 7H9 broth supplemented with 10% oleic acid-albumin-dextrose-calatase (OADC; Difco Laboratories, Detroit, Mich.), 0.05% Tween 80 (Sigma Chemical Co.), and 2 g of mycobactin J (Allied Monitor, Inc., Fayette, Mo.) per ml. The bacteria were harvested, washed three times in phosphate-buffered saline (PBS) with 0.05% Tween 80, and dispersed as a predominantly single-cell suspension with a motor-driven overhead stirrer and glass-Teflon homogenizer (Wheaton Instruments, Millville, N.J.). The bacteria were resuspended in 7H9 broth containing 0.05% Tween 80, 10% OADC, and 10% FBS and stored at Ϫ70ЊC.
Monocyte activation. Monocytes were pretreated with 0.01 to 1 g of rIFN-␥ (lot 3229; 95% purity, 2.2 ϫ 10 6 U/mg of protein; generously donated by G. Burton, Genentech, S. San Francisco, Calif.) for 16 to 18 h before being infected with M. avium subsp. paratuberculosis. To assess the effect of nitric oxide, the monocytes were cultured with 0.1 g of rIFN-␥ per ml alone or with 0.1 g of rIFN-␥ per ml and 250 M N G -monomethyl-L-arginine (NMMA; Sigma), a competitive inhibitor of nitric oxide production, for 16 to 18 h before the monocytes were infected with M. avium subsp. paratuberculosis. At the time of infection, 1 g of LPS (Escherichia coli O11:B4-W; Sigma) was added to monocytes pretreated with rIFN-␥ alone or with rIFN-␥ and NMMA to induce maximal nitric oxide production (47) .
Infection of monocytes. Monocytes were incubated in tissue culture medium with or without rIFN-␥ or rIFN-␥-NMMA for 16 to 24 h. Monocytes were then infected with M. avium subsp. paratuberculosis at a 10:1 ratio of bacteria to monocytes in the presence of 10% fresh autologous serum for 120 min at 39ЊC in 5% CO 2 . Subsequently, the monolayers were washed three times with warm HBSS to remove extracellular bacteria and complete RPMI 1640 was added. The plates were incubated at 39ЊC for up to 12 days, and the culture medium was replaced with fresh medium at 3, 6, and 9 days after infection. The same concentrations of rIFN-␥, LPS, and NMMA originally present were also added to the wells whenever the medium was changed. When the medium was replaced, the conditioned medium was retained for bacterial quantification. The integrity of the monolayers was monitored by inverted light microscopy. Monocytes were 85 to 90% viable after 12 days of infection, as determined by trypan blue exclusion, and were reduced in number approximately 20 to 30% during that time compared with the number of cells originally adherent.
The effect of timing of rIFN-␥ treatment on the intracellular fate of M. avium subsp. paratuberculosis. Monocytes were incubated in tissue culture medium with or without rIFN-␥ for 16 to 18 h and then infected with M. avium subsp. paratuberculosis as described above. After infection, one group of the rIFN-␥-pretreated monocytes was cultured continuously with rIFN-␥ while another group was cultured in medium without rIFN-␥. In addition, rIFN-␥ was added to one group of untreated monocytes after they were infected with M. avium subsp. paratuberculosis while the remaining group of untreated monocytes was not exposed to rIFN-␥. All groups of monocytes were cultured for 12 days after infection, and the numbers of intracellular M. avium subsp. paratuberculosis cells were then assessed.
Assessment of viable intracellular M. avium subsp. paratuberculosis. The number of viable intracellular M. avium subsp. paratuberculosis cells was determined by radiometric (BACTEC) and traditional plate counting (CFU) methods. Duplicate monolayers were harvested at 2 h and at 3, 6, 9, and 12 days after infection by lysing them with 0.25% sodium dodecyl sulfate (SDS). The conditioned media and monolayer lysates were stored at Ϫ70ЊC until all lysates were collected. The conditioned media and cell lysates for each time point were then thawed, pooled, and centrifuged at 700 ϫ g for 30 min. The pellets were resuspended and inoculated into BACTEC 12B vials supplemented with 2 g of mycobactin J per ml and 1 ml of egg yolk. The growth index (measurement of 14 CO 2 ) was recorded every 24 h by the BACTEC 460 instrument until the cumulative growth indices reached 2,000 (usually in 20 days). The log 10 numbers of viable M. avium subsp. paratuberculosis cells were determined by the following formula, as described previously (30): 
For plate counts, the cell pellets were each resuspended in 2 ml of PBS and dispersed into predominantly single-cell suspensions with a motor-driven overhead stirrer and glass-Teflon homogenizer (Wheaton Instruments). Tenfold serial dilutions of the suspensions were plated (0.1 ml) on 7H9 agar plates supplemented with OADC and 2 g of mycobactin J per ml. The plates were incubated for 30 days, and then the numbers of CFU were enumerated without magnification. We confirmed that the concentration of SDS (0.25%) needed to lyse the monocytes did not adversely affect the viability of M. avium subsp. paratuberculosis. To do this, suspensions of the bacilli were treated with SDS for 40 min, frozen at Ϫ70ЊC overnight, and then thawed the next day and inoculated into BACTEC vials. The results indicated that up to 1% SDS did not affect the viability of M. avium subsp. paratuberculosis (data not shown).
Effect of rIFN-␥ on the uptake of M. avium subsp. paratuberculosis by monocytes. Monocytes from three cows were allowed to adhere to glass coverslips and then treated with 0.1 g of rIFN-␥ per ml for 18 h. The monocytes were infected with M. avium subsp. paratuberculosis, and uptake of this organism was assayed by microscopic counting of coverslips as previously described (49), with some modifications. Briefly, glass coverslips with adherent infected monolayers were removed from the wells after 2 h of infection, allowed to air dry, acid-fast stained, and examined by light microscopy (magnification, ϫ1,000). Duplicate coverslips were examined for each treatment group, and 100 monocytes in four to five fields per coverslip were counted. Monocytes were scored for the ingestion of acid-fast bacilli (AFB) and for the number of intracellular AFB. The mean numbers of AFB per infected monocyte were calculated by dividing the total numbers of AFB by the total numbers of infected monocytes.
Measurement of NO 2 ؊. To detect production of nitric oxide by monocytes, its stable end product, NO 2 Ϫ, was analyzed by the Griess reaction (21) . Briefly, conditioned media were collected and centrifuged (400 ϫ g) for 10 min. Aliquots (50 l) of the conditioned media were then distributed in a 96-well microtiter plate, and then equal volumes of the Griess reaction solutions (0.1% naphthylethylenediamine dihydrochloride and 1% sulfanilamide in 2.5% phosphoric acid) were added. The reaction was allowed to proceed for 10 min at room temperature, and the absorbance at 550 nm was measured with a model 312 BioTek enzyme-linked immunosorbence assay reader. The amounts of NO 2 Ϫ in the samples were calculated by extrapolation from a sodium nitrite standard curve prepared for each experiment.
Assessment of the antimycobacterial effect of chemically generated nitric oxide. The BO45 strain of M. avium subsp. paratuberculosis and a field isolate of M. avium (from a bird with avian tuberculosis) were incubated in the absence of monocytes with various concentrations of the nitric oxide donor S-nitroso-Nacetyl penicillamine (SNAP) (Calbiochem, La Jolla, Calif.), which has been used previously for in vitro microbial killing assays (28) . One milligram of SNAP was dissolved in 1 ml of dimethyl sulfoxide (DMSO) immediately before use, and this solution was then serially diluted in 1 ml of either 7H9 broth or RPMI 1640 tissue culture medium. Approximately 10 6 M. avium subsp. paratuberculosis cells were incubated at 39ЊC for 24 h with a range of concentrations of SNAP. Controls included bacilli incubated with medium alone or in medium with DMSO. The organisms were then washed three times with PBS, resuspended in 7H9 broth, and inoculated into BACTEC vials to determine the numbers of viable bacilli. The amount of nitric oxide in the supernatant was determined by the Griess reaction, as described above.
Data analysis. All data were analyzed by a one-way analysis of variance, or by repeated-measures analysis of variance, using the InStat software package (GraphPad Software, San Diego, Calif.). For all tests, values of P Ͻ0.05 were considered to be significant.
RESULTS

Uptake of M. avium subsp. paratuberculosis cells by rIFN-␥-pretreated monocytes.
Monocytes preincubated with rIFN-␥-ingested more M. avium subsp. paratuberculosis cells (average, 7.3 AFB/infected monocyte) than did untreated monocytes (average, 5.1 AFB/infected monocyte) from three separate cows. There was no difference between rIFN-␥-treated monocytes and untreated monocytes in the percentage of monocytes initially infected with M. avium subsp. paratuberculosis (44.7 and 42.2%, respectively).
Intracellular growth of M. avium subsp. paratuberculosis in rIFN-␥-treated bovine monocytes. We first determined that all reagents used in the study (complete RPMI medium supplemented with rIFN-␥, LPS, or NMMA) neither supported nor inhibited the growth of M. avium subsp. paratuberculosis compared with bacilli incubated in 7H9 broth (Fig. 1) . We next showed that monocytes pretreated with rIFN-␥ inhibited the intracellular growth of M. avium subsp. paratuberculosis through 8 days of in vitro incubation (Fig. 2) . The inhibitory effect of rIFN-␥ was dose dependent, with a maximal inhibitory effect achieved at 1 g of rIFN-␥ per ml (Fig. 2) . This concentration of IFN-␥, however, is not likely to be physiologically achievable (46) . Because of this, 0.1 g of rIFN-␥ per ml was used to treat monocytes in subsequent experiments. We also prolonged the culture time from 8 to 12 days after infection because of the slow growth rate of M. avium subsp. paratuberculosis.
We next compared the effects of exposing bovine monocytes to rIFN-␥ before and after infection with M. avium subsp. paratuberculosis on the subsequent intracellular growth of the bacilli. This was done with monocytes from four animals, with the results of two animals being determined by the standard plate count method and the results of the other two animals being determined by the BACTEC method (Table 1) . Although the numbers of intracellular M. avium subsp. paratuberculosis cells estimated by the BACTEC and plate counts methods differed somewhat, the trends were similar. This is consistent with our separate report, which showed that the BACTEC and plate count methods indicated similar patterns of intracellular bacillary survival (48) . In monocytes not treated with rIFN-␥, the numbers of viable intracellular M. avium subsp. paratuberculosis cells increased approximately threefold as determined by CFU and by 0.7 log 10 as determined by the BACTEC method at 6 days after infection (Table 1 , treatment A). In monocytes exposed to rIFN-␥ only after infection with M. avium subsp. paratuberculosis, the numbers of intracellular M. avium subsp. paratuberculosis increased about twofold as determined by CFU and by 0.6 log 10 as determined by the BACTEC method at 6 days after infection (Table 1 , treatment B). In monocytes that were pretreated with rIFN-␥ but not exposed to rIFN-␥ after infection, there was a twofold increase as determined by CFU and an approximately 0.7 log 10 increase as determined by the BACTEC method at 6 days after infection (Table 1, Nitric oxide production was not related to the inhibitory effect of rIFN-␥ on M. avium subsp. paratuberculosis in bovine monocytes. We next examined the possible effects of NO on the intracellular survival of M. avium subsp. paratuberculosis. NO was produced by infected monocytes treated with rIFN-␥ alone, was increased somewhat in infected monocytes treated with rIFN-␥ and LPS (Fig. 3A) , and was inhibited when NMMA was added to monocytes cultured with rIFN-␥ and LPS (Fig. 3A) . The numbers of intracellular M. avium subsp. paratuberculosis cells increased significantly (P Ͻ 0.05), to 0.3 log 10 , in control monocytes at 6 days after infection and then started to decline (Fig. 3B) . In monocytes pretreated with rIFN-␥ alone, the numbers of intracellular M. avium subsp. paratuberculosis increased only slightly at 3 days after infection and then started to decline. This decline in viable counts occurred 3 days earlier than that observed in the control monocytes (Fig. 3B) . Neither enhancement nor inhibition of nitric oxide production substantially altered the pattern of intracellular survival of M. avium subsp. paratuberculosis in bovine monocytes, although the number of M. avium subsp. paratuberculosis cells in monocytes treated with rIFN-␥ and LPS was slightly higher than in monocytes treated with rIFN-␥ alone or in monocytes treated with rIFN-␥, LPS, and NMMA (Fig. 3B) .
The effect of chemically generated nitric oxide on survival of M. avium subsp. paratuberculosis. The preceding experiments suggested that NO might not be a major effector molecule for inhibiting intracellular M. avium subsp. paratuberculosis. We decided to further address this question by incubating M. avium subsp. paratuberculosis with a chemical compound (SNAP) that generates NO. We found that the numbers of viable M. avium subsp. paratuberculosis decreased as the concentration of nitrite produced by SNAP increased, in both 7H9 broth and RPMI 1640 (Table 2 ). These data suggest that M. avium subsp. paratuberculosis can be killed by the nitric oxide generated by SNAP, but killing of greater than 1 log 10 of M. avium subsp. paratuberculosis cells requires approximately 200 M nitrite (Table 2) versus the 1 to 5 M concentration released by bovine monocytes (Fig. 3A) . Similar results were obtained with M. avium (data not shown).
DISCUSSION
In this study, we investigated the effects of rIFN-␥ and inducible nitric oxide on the intracellular survival of M. avium 3 . The effect of rIFN-␥ and inducible nitric oxide on intracellular growth of M. avium subsp. paratuberculosis (MPTB). Monocytes were treated with 0.1 g of rIFN-␥ per ml or with 0.1 g of rIFN-␥ per ml and 250 M NMMA for 18 h before infection. LPS (1 g/ml) was added to the monocytes when they were infected with MPTB. The same reagents were present in the tissue culture media continuously for 12 days after infection. Conditioned media were assayed for nitrite by the Greiss reaction (A). The numbers of viable intracellular MPTB (B) were determined by the BACTEC method as described in Materials and Methods. The results shown are the mean log 10 changes in numbers of viable bacilli of five experiments using four different donor animals (one of which was sampled twice). Although not illustrated, standard deviations are less than 0.1 log 10 CFU for all the data points.
subsp. paratuberculosis in bovine monocytes. In the initial experiments, monocytes pretreated with rIFN-␥ inhibited the intracellular growth of M. avium subsp. paratuberculosis through 8 days of infection in vitro. Maximal inhibition was achieved in monocytes pretreated with 1 g of rIFN-␥ per ml (Fig. 2) . However, this concentration is higher than what can be likely achieved in vivo. We have observed previously that PBLs from cows experimentally infected with M. avium subsp. paratuberculosis produce only 2.5 ng of IFN-␥ per ml of plasma when stimulated ex vivo with M. avium PPD (46) . In the present study, we found that monocytes pretreated with 0.1 g of rIFN-␥ per ml ingested slightly greater numbers of M. avium subsp. paratuberculosis cells. This is consistent with a previous report stating that bovine monocytes pretreated with crude IFN-␥, IFN-␣, or rIFN-␥ ingested higher numbers of M. avium subsp. paratuberculosis cells than did untreated monocytes (50). Our results do not agree with the report of Toba et al., who observed that IFN-␥ reduced uptake of M. avium by human monocytes (44) .
We observed that rIFN-␥ failed to dramatically increase the antimycobacterial activity of bovine monocytes, regardless of when the rIFN-␥ was added (Table 1 and Fig. 3B ). Our results are consistent with previous reports that recombinant human IFN-␥ consistently failed to activate human monocytes to inhibit intracellular growth of M. tuberculosis (16, 33, 40) and M. avium (44) . Our results also confirmed a previous report stating that rIFN-␥ was ineffective in activating bovine monocytes to inhibit intracellular growth of M. avium subsp. paratuberculosis (50) . That earlier finding was based on microscopic enumeration of intracellular AFB rather than the BACTEC assay used in the present study. We find that the BACTEC method is more sensitive than microscopic enumeration of AFB, which cannot distinguish viable bacilli from injured or dead bacilli. Furthermore, the percentages of infected monocytes noted in the earlier and present studies were comparable (approximately 40%). Thus, we feel that the two studies are relatively consistent and that they support our current contention that rIFN-␥ has, at most, a modest inhibitory effect on the multiplication of M. avium subsp. paratuberculosis in bovine monocytes.
Interestingly, we observed that IFN-␥ was produced when PBLs from seven of seven cows experimentally infected with M. avium subsp. paratuberculosis were stimulated ex vivo with M. avium PPD (46) . Reduction of the ex vivo IFN-␥ response of bovine PBLs was associated with disease progression in two cows (46) . Failure of rIFN-␥ to sufficiently activate the antimycobacterial activity of bovine monocytes in vitro suggests that it might be necessary for some other cytokine(s), such as TNF-␣ or interleukin-12, to act in concert with IFN-␥ to activate bovine monocytes in vitro and in vivo. Alternatively, perhaps IFN-␥ can effectively activate local tissue macrophages to inhibit or kill mycobacteria, but not circulating monocytes. Another possibility is that M. avium subsp. paratuberculosis is resistant to the killing mechanisms of bovine monocytes, even after they are activated by rIFN-␥ (5, 38) .
In the present study, we found that induction of nitric oxide was not related to the slight inhibitory effect of rIFN-␥ on intracellular survival of M. avium subsp. paratuberculosis in bovine monocytes. While it is difficult to compare results among different species, our findings are contrary to previous reports stating that induction of nitric oxide is related to antimycobacterial activity in murine macrophages (8, 12, 19, 41 ). There may be several possible reasons for the observed differences among the various reports. Activated bovine mononuclear phagocytes might have different antimycobacterial mechanisms than activated murine macrophages. Also, we used peripheral blood monocytes, instead of the bone marrow-derived macrophages or peritoneal macrophages used in most murine studies (8, 12, 19, 41) . It has been shown that IFN-␥ does not have the same effect on different populations of mononuclear phagocytes. In one study, murine peritoneal macrophages were activated by IFN-␥ to inhibit intracellular growth of virulent M. tuberculosis H37Rv. Similar activation was not observed in human monocytes (40) . Based on our results, it appears that the amount of nitric oxide produced by bovine monocytes stimulated with either rIFN-␥ alone or rIFN-␥ plus LPS was insufficient to kill M. avium subsp. paratuberculosis. This is supported by our observation that the amount of chemically generated nitric oxide needed to kill M. avium subsp. paratuberculosis in the cell-free system (Table 2) was substantially higher than the amounts of nitric oxide released by activated bovine monocytes (Fig. 3A) . It should be noted that the concentrations of nitric oxide needed to kill M. avium subsp. paratuberculosis (Table 2) might not be achievable in the intracellular microenvironment.
Our data suggest that rIFN-␥ can activate bovine monocytes, as indicated by induction of nitric oxide, but that this activation is inadequate to sustain a prolonged inhibition of intracellular M. avium subsp. paratuberculosis. Our data also suggest that the amount of nitric oxide produced by activated bovine monocytes in vitro may be insufficient to kill or inhibit intracellular M. avium subsp. paratuberculosis. These findings suggest that production of nitric oxide by activated bovine mononuclear phagocytes might not be a major antimycobacterial mechanism against M. avium subsp. paratuberculosis infection. 
